jfs2152

VBIV target [$3.50] by July 1st

做多
jfs2152 已更新   
NASDAQ:VBIV   VBI Vaccines, Inc.
Expect a significant appreciation in price leading up to the upcoming poster presentation of Phase 1/2a data of VBI-1901 in Recurrent GBM Patients at AACR virtual annual meeting.
评论:
Large MACD divergence into what seems like price consolidation. Expecting a big move within the next 3-5 days.


免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。